XML 156 R170.htm IDEA: XBRL DOCUMENT v2.4.1.9
Outstanding and Exercisable SARs by Grant Price (Detail) (Stock Appreciation Rights, USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of SARs Outstanding at Year End 45,590us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber 48,599us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber 44,120us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber 36,502us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Outstanding SARs Weighted-Average Grant Price $ 19.79us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue $ 19.98us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue $ 20.41us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue $ 22.20us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
Outstanding Weighted-Average Remaining Contractual Life 5 years 9 months 18 days      
Number of SARs Exercisable at Year End 27,950fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber      
Weighted-Average Grant Price $ 21.71fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1 $ 24.14fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1 $ 26.76fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1  
Exercisable Weighted-Average Remaining Contractual Life 4 years 3 months 18 days      
Under $10.00        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of SARs Outstanding at Year End 3,363us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range1Member
     
Outstanding SARs Weighted-Average Grant Price $ 3.98us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range1Member
     
Outstanding Weighted-Average Remaining Contractual Life 4 years 3 months 18 days      
Number of SARs Exercisable at Year End 3,360fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range1Member
     
Weighted-Average Grant Price $ 3.99fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range1Member
     
Exercisable Weighted-Average Remaining Contractual Life 4 years 3 months 18 days      
$10.01-$20.00        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of SARs Outstanding at Year End 29,089us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range2Member
     
Outstanding SARs Weighted-Average Grant Price $ 15.36us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range2Member
     
Outstanding Weighted-Average Remaining Contractual Life 6 years 8 months 12 days      
Number of SARs Exercisable at Year End 15,783fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range2Member
     
Weighted-Average Grant Price $ 15.54fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range2Member
     
Exercisable Weighted-Average Remaining Contractual Life 5 years 10 months 24 days      
$20.01-$30.00        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of SARs Outstanding at Year End 4,362us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range3Member
     
Outstanding SARs Weighted-Average Grant Price $ 21.64us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range3Member
     
Outstanding Weighted-Average Remaining Contractual Life 9 years 3 months 18 days      
Number of SARs Exercisable at Year End 31fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range3Member
     
Weighted-Average Grant Price $ 22.73fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range3Member
     
Exercisable Weighted-Average Remaining Contractual Life 3 years 4 months 24 days      
$30.01-$40.00        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of SARs Outstanding at Year End 6,443us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range4Member
     
Outstanding SARs Weighted-Average Grant Price $ 38.67us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range4Member
     
Outstanding Weighted-Average Remaining Contractual Life 1 year 8 months 12 days      
Number of SARs Exercisable at Year End 6,443fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range4Member
     
Weighted-Average Grant Price $ 38.67fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range4Member
     
Exercisable Weighted-Average Remaining Contractual Life 1 year 8 months 12 days      
Over $40.00        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of SARs Outstanding at Year End 2,333us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range5Member
     
Outstanding SARs Weighted-Average Grant Price $ 42.16us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range5Member
     
Outstanding Weighted-Average Remaining Contractual Life 0 years 9 months 18 days      
Number of SARs Exercisable at Year End 2,333fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range5Member
     
Weighted-Average Grant Price $ 42.16fitb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantPrice1
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
/ fitb_GrantPriceRangeAxis
= fitb_Range5Member
     
Exercisable Weighted-Average Remaining Contractual Life 0 years 9 months 18 days